Haemonetics HAE
NYSE HAE
$101.14 -2.02 (-1.96%)
As of: Sep 10, 2026 · 3:59 PM EDT

Haemonetics (HAE) Revenue Growth (5y) (2014 - 2026)

Analysis

Haemonetics (HAE) Revenue Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Haemonetics 4.60 Bn 4.37 Bn 202.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 8.23%
Mar 28, 2026 9.01%
Dec 27, 2025 7.12%
Sep 27, 2025 9.34%
Jun 28, 2025 10.44%
Mar 29, 2025 6.75%
Dec 28, 2024 6.12%
Sep 28, 2024 6.47%
Jun 29, 2024 7.11%
Mar 30, 2024 6.61%
Dec 30, 2023 6.33%
Sep 30, 2023 5.66%
Jul 1, 2023 6.30%
Apr 1, 2023 5.44%
Dec 31, 2022 5.46%
Oct 1, 2022 5.71%
Jul 2, 2022 4.39%
Apr 2, 2022 3.05%
Jan 1, 2022 2.66%
Oct 2, 2021 1.72%